ANTX
NASDAQ · Pharmaceuticals
An2 Therapeutics Inc
$5.16
+0.18 (+3.61%)
Open$5.03
Previous Close$4.98
Day High$5.25
Day Low$4.95
52W High$6.91
52W Low$1.00
Volume—
Avg Volume249.1K
Market Cap180.08M
P/E Ratio—
EPS$-1.10
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+259.5% upside
Current
$5.16
$5.16
Target
$18.55
$18.55
$11.23
$18.55 avg
$22.80
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 8.24M | 7.98M | 7.65M |
| Net Income | 1.80M | 1.81M | 1.71M |
| Profit Margin | 21.9% | 22.7% | 22.3% |
| EBITDA | 3.67M | 3.33M | 3.32M |
| Free Cash Flow | 1.39M | 970.9K | 896.1K |
| Rev Growth | -4.4% | +17.2% | +22.3% |
| Debt/Equity | 1.44 | 1.37 | 1.29 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,114.20 | +0.64% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $240.15 | +0.45% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $121.17 | +1.31% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.09 | -2.55% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $78.15 | +1.70% | 12.5 | 33.00B |